SalivaDirect: an alternative to a conventional RNA extraction protocol for molecular detection of SARS-CoV-2 in a clinical setting

Microbiol Spectr. 2024 Jan 11;12(1):e0327223. doi: 10.1128/spectrum.03272-23. Epub 2023 Nov 28.

Abstract

Affordable and accessible tests for COVID-19 allow for timely disease treatment and pandemic management. SalivaDirect is a faster and easier method to implement than NPS sampling. Patients can self-collect saliva samples at home or in other non-clinical settings without the help of a healthcare professional. Sample processing in SalivaDirect is less complex and more adaptable than in conventional nucleic acid extraction methods. We found that SalivaDirect has good diagnostic performance and is ideal for large-scale testing in settings where supplies may be limited or trained healthcare professionals are unavailable.

Keywords: COVID-19; Nasopharyngeal swab; RT-qPCR; SARS-CoV-2; Saliva; SalivaDirect.

MeSH terms

  • COVID-19* / diagnosis
  • Health Personnel
  • Humans
  • Pandemics
  • RNA
  • SARS-CoV-2* / genetics
  • Saliva
  • Specimen Handling

Substances

  • RNA